Treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes (see Pharmacology: Pharmacodynamics under Actions).
Treatment of severe vernal keratoconjunctivitis (VKC) in children and adolescents from 4 to 18 years old.